Efficacy of intermittent liposomal amphotericin B in the treatment of visceral leishmaniasis in patients infected with human immunodeficiency virus - PubMed (original) (raw)
Efficacy of intermittent liposomal amphotericin B in the treatment of visceral leishmaniasis in patients infected with human immunodeficiency virus
F Laguna et al. Clin Infect Dis. 1995 Sep.
No abstract available
Similar articles
- Efficacy of liposomal amphotericin B in the treatment of visceral leishmaniasis in patients coinfected with the human immunodeficiency virus.
Torre-Cisneros J, Villanueva JL. Torre-Cisneros J, et al. Clin Infect Dis. 1995 Jan;20(1):191. doi: 10.1093/clinids/20.1.191. Clin Infect Dis. 1995. PMID: 7727652 No abstract available. - Efficacy of liposomal amphotericin B in the treatment and secondary prophylaxis of visceral leishmaniasis in HIV infected patients: report of two cases.
Lopez Dupla M, Gil Aguado A, Lavilla Uriol P, Pintado Garcia V, Valencia Ortega E, Martinez Martinez P, Garcia-Puig J. Lopez Dupla M, et al. J Antimicrob Chemother. 1993 Oct;32(4):657-9. doi: 10.1093/jac/32.4.657. J Antimicrob Chemother. 1993. PMID: 8288512 No abstract available. - Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus.
Torre-Cisneros J, Villanueva JL, Kindelan JM, Jurado R, Sanchez-Guijo P. Torre-Cisneros J, et al. Clin Infect Dis. 1993 Oct;17(4):625-7. doi: 10.1093/clinids/17.4.625. Clin Infect Dis. 1993. PMID: 8268341 Review. - Cutaneous manifestations of visceral leishmaniasis resistant to liposomal amphotericin B in an HIV-positive patient.
Alsina-Gibert M, López-Lerma I, Martinez-Chamorro E, Herrero-Mateu C. Alsina-Gibert M, et al. Arch Dermatol. 2006 Jun;142(6):787-9. doi: 10.1001/archderm.142.6.787. Arch Dermatol. 2006. PMID: 16785393 No abstract available. - Liposomal amphotericin B and rHuGM-CSF for treatment of visceral leishmaniasis in AIDS.
Mastroianni A. Mastroianni A. Infez Med. 2004 Sep;12(3):197-204. Infez Med. 2004. PMID: 15711134 Review.
Cited by
- Liposomal amphotericin B and leishmaniasis: dose and response.
Sundar S, Chakravarty J. Sundar S, et al. J Glob Infect Dis. 2010 May;2(2):159-66. doi: 10.4103/0974-777X.62886. J Glob Infect Dis. 2010. PMID: 20606972 Free PMC article. - Short- and long-term efficacy of hexadecylphosphocholine against established Leishmania infantum infection in BALB/c mice.
Le Fichoux Y, Rousseau D, Ferrua B, Ruette S, Lelièvre A, Grousson D, Kubar J. Le Fichoux Y, et al. Antimicrob Agents Chemother. 1998 Mar;42(3):654-8. doi: 10.1128/AAC.42.3.654. Antimicrob Agents Chemother. 1998. PMID: 9517947 Free PMC article. - Leishmania and human immunodeficiency virus coinfection: the first 10 years.
Alvar J, Cañavate C, Gutiérrez-Solar B, Jiménez M, Laguna F, López-Vélez R, Molina R, Moreno J. Alvar J, et al. Clin Microbiol Rev. 1997 Apr;10(2):298-319. doi: 10.1128/CMR.10.2.298. Clin Microbiol Rev. 1997. PMID: 9105756 Free PMC article. Review. - Visceral leishmaniasis in patients infected with the human immunodeficiency virus.
Laguna F, Adrados M, Alvar J, Soriano V, Valencia ME, Moreno V, Polo R, Verdejo J, Jiménez MI, Martínez P, Martínez ML, González-Lahoz JM. Laguna F, et al. Eur J Clin Microbiol Infect Dis. 1997 Dec;16(12):898-903. doi: 10.1007/BF01700556. Eur J Clin Microbiol Infect Dis. 1997. PMID: 9495670 - Comparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniasis.
Mullen AB, Carter KC, Baillie AJ. Mullen AB, et al. Antimicrob Agents Chemother. 1997 Oct;41(10):2089-92. doi: 10.1128/AAC.41.10.2089. Antimicrob Agents Chemother. 1997. PMID: 9333030 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical